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Recent advances in food allergy
Tópicos recentes em alergia alimentar
Summary
Food allergy is a public health issue that has significantly increased worldwide in the past decade, affecting consumers’ 
quality of life and making increasing demands on health service resources. Despite recent advances in many areas of 
diagnosis and treatment, our general knowledge of the basic mechanisms of the disease remain limited i.e., not at pace with 
the exponential number of new cases and the explosion of new technologies. Many important key questions remain: What 
defines a major allergen? Why do some individuals develop food allergies and others do not? Which are the environmental 
factors? Could the environmental factors be monitored through epigenetics or modified by changes in the microbiome? Can 
tolerance to food be induced? Why are some foods more likely to trigger allergies than others? Does the route and timing of 
exposure have any role on sensitization? These and many other related questions remain unanswered. In this short review 
some of these topics are addressed in the light of recent advances in the area.
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Resumo
A alergia alimentar é uma questão de saúde pública que tem aumentado significativamente na última década em todo 
o mundo, afetando a qualidade de vida dos consumidores e fazendo demandas crescentes sobre os recursos dos serviços 
de saúde. Apesar dos recentes avanços em muitas áreas de diagnóstico e tratamento, o nosso conhecimento geral dos 
mecanismos básicos da doença permanecem limitados, isto é, não avança no mesmo ritmo exponencial de novos casos 
e chegada de novas tecnologias. Muitas questões importantes permanecem: O que define um alérgeno principal? Por que 
algumas pessoas desenvolvem alergias alimentares e outras não? Quais são os fatores ambientais? Poderiam os fatores 
ambientais serem monitorados através de técnicas epigenéticas ou modificados por mudanças no microbioma? Poderia 
tolerância ao alimento ser induzida? Por que alguns alimentos são mais propensos a desencadear alergias do que outros? 
Será que a rota e tempo de exposição têm qualquer papel na sensibilização? Estas e muitas outras questões relacionadas 
permanecem sem resposta. Nesta breve revisão, alguns destes tópicos são abordados à luz dos recentes avanços na área.
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1 Introduction
Food allergy is a public health issue that has significantly 
increased worldwide in the past decade, affecting consumers’ 
quality of life and making increasing demands on health service 
resources (CIANFERONI; SPERGEL, 2009; LIEBERMAN; 
SICHERER, 2010, BURKS et al., 2012). According to EAACI 
reports, approximately 17 million people in Europe are suffering 
from food-related allergies and critical hospital admission for 
children has increased by 7-fold within the past 10 years. 
Food allergy affects around 2-4% of the population peaking 
at 6-8% at 1 year of age and declining gradually to 2-4% in 
older children and adults (RONA et al., 2007; ZUIDMEER et al., 
2008, MADSEN et al., 2009). This decline reflects the fact 
that many infants grow out of their food allergies as they 
age. The rate and probability of resolution varies significantly 
between specific foods. Frequently, egg, milk, wheat and soy 
allergies resolve relatively early in life, whereas allergies to 
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peanuts, tree nuts, sesame seeds, fish, crustacean shellfish 
and buckwheat tend to persist. However it remains unclear 
why some children or adults achieve natural tolerance 
and others do not. Interestingly, several studies indicate 
that 75% of allergic reactions among children are linked 
to a limited number of foods, which include egg, peanut, 
cow’s milk, fish and various nuts. Conversely in adults, 
fruits of the latex group (e.g. kiwi, banana), fruits of the 
Rosaceae family (e.g. apples, pears, prunes), vegetables 
of the Apiaceae family (e.g. carrot, celery), and various 
nuts and peanuts are responsible for 50% of allergic 
reactions (KANNY et al., 2001, SASTRE, 2010; DUPONT, 
2011; GADERMAIER et al., 2011).
Several analytical approaches have been developed 
for the detection and quantification of allergens in food 
products. These techniques target either the allergen itself 
or a corresponding allergen marker (peptide fragment or 
gene segment). Due to the diverse nature of food allergens 
and the complexity of the respective food matrices, the 
choice of detection methods can be challenging at times. 
With the recent advances in molecular biology, biochip 
technology, mathematical modelling amongst others 
and access to large volume of information on genomics, 
genomic associated studies, cell culture, cell engineering, 
microbiome and many of the new omics, the whole 
diagnostic, therapeutic and basic immunology area of food 
allergy is undergoing great transformation. This is a major 
contrast with the accumulated knowledge of the basic 
mechanisms of the disease. Since the pioneering work in 
the early 1920s demonstrating the transfer of sensitivity 
to a non-allergic person and the discovery of IgEs in the 
50s, our general knowledge of the basic mechanisms of 
the disease has remained limited i.e., not at pace with the 
exponential number of new cases and the explosion of 
new technologies. Many important key questions remain: 
What defines a major allergen? Why do some individuals 
develop food allergies and others do not? Which are the 
environmental factors? Could the environmental factors be 
monitored through epigenetics or modified by changes in 
the microbiome? Can tolerance to food be induced? Why 
are some foods more likely to trigger allergies than others? 
Does the route and timing of exposure have any role on 
sensitization? These and many other related questions 
remain unanswered.
In general terms, food allergy can be defined as an 
immune-mediated sensitivity to food proteins (BOYCE et al., 
2010). It is essentially «immunity gone wrong» where 
normally harmless substances (food allergens) are perceived 
as a threat and acted upon by the body’s immunological 
defences. In a type I hypersensitivity reaction the adaptive 
immune system responds by producing IgE antibodies 
against the allergens. It is a two-step process where the 
capacity to respond through an allergic reaction when 
exposed to the particular allergen must be first established. 
This induces the immune system to generate specific IgE 
antibodies against the allergen in a so-called induction 
phase, or sensitization. Once sensitized to a particular 
allergen, the individual may develop a symptomatic allergic 
reaction when exposed again to the allergen in question 
in a provocation or later triggering phase (SICHERER; 
SAMPSON, 2010).
Interestingly what defines a major allergen is still 
largely unknown. More importantly the intrinsic factors 
that differentiate a common everyday food protein from 
a fatal allergen to a particular group of patients remain 
largely unknown. Despite the attempts by a large number 
of groups to define the basic intrinsic characteristics of an 
allergenic protein, only 2 mechanisms, both described in 
the Dermatophagoides pteronyssinus (house dust mite), 
are currently known: a protease dependent one (Der p 1) 
and a protease independent one (Der p 2). In the former, 
Der p 1 protease activity has been shown to cleave CD23, 
CD25 and CD40, inhibiting IL-12 secretion with the possible 
activation of the PAR family of G coupled proteins in the 
process (KAUFFMAN et al., 2006). In the latter mechanism, 
it has been elegantly shown that Der p 2 structurally mimics 
MD2, a component of the TLR4 complex that can co-opt 
other signalling components to activate its target cells 
(TROMPETTE et al., 2009). Hence the involvement of complex 
lipids and Toll receptors has been clearly demonstrated. 
However, as most of the well-characterised allergens are 
not proteases and it is unlikely that MD2 homology could 
be a general mechanism for allergenicity, this suggests 
that other mechanisms certainly exist.
This means that current understanding of the 
molecular mechanisms underlying the development of IgE 
responses is incomplete and as a result any risk assessment 
regarding allergenicity has to rely on historic evidences. 
Factors such as the age when the initial sensitization 
occurred, genetic susceptibility, environmental factors 
including geographic distribution, exposure route, type 
of food, food matrixes and adjuvants, amongst many 
others, should be considered. As a consequence of this 
complexity decision-tree approaches have been proposed 
to facilitate allergenicity assessment. The classical 
International Life Science Institute decision tree of 1996 (ILSI) 
(METCALFE et al., 1996) and its revised version proposed 
by a joint FAO/WHO committee (WHO; FAO, 2001) are 
examples of these. Although no longer followed by many 
European countries, the essential information contained in 
these decision-trees i.e. relationships between novel proteins 
and known allergens, cross-reactivity defined using patient 
allergic sera, in vitro measures of protein digestibility, in 
vivo sensitisation using animal models, and bioinformatics 
data, are still used today as important parameters for 
the approval of novel food proteins. The criticisms and 
limitations of the different approaches currently used in 
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the assessment of allergenicity are out of the scope of 
this article, hence alternative methodologies are sought.
2 Protein arrays
In the search for alternative methods for allergenicity 
assessment, protein chip technology has been shown 
to be a convenient tool for the measurement of specific 
allergen IgE levels. However, its application in the 
diagnosis of food allergy has been hampered by at least 
two basic factors: representativeness and lack of clinical 
support. With the availability of a great number of genomic 
sequences and NMR/crystallographic structural studies 
it is now possible to trace the taxonomy and genetic 
relationships of a great number of common allergens and 
their progenitor plant, insect, parasite or animal cells. 
The newly acquired knowledge adds to our understanding 
of ordinary cross-reactivities of physiological importance. 
One interesting outcome from these studies is the shear 
realization of the dauntingly large number of proteins our 
body is exposed to daily. Several domesticated crops, for 
instance, possess a genome size that in many cases is 
several folds larger than the human genome. Hence the 
representation by groups of cross-reacting substance or 
a few hundred biological markers as present in current 
commercial protein arrays, are orders of magnitude 
away from the actual representation faced daily by our 
immune system. Thus despite the heavy investments on 
the array area trying to demonstrate otherwise the whole 
representativeness area is very much open to debate. 
The second factor that restricts the acceptance of the arrays 
in diagnostics refers to the fact that they only measure 
the presence of allergen-specific immunoglobulin in vitro, 
which in most cases does not necessarily correlate with 
the observed clinical symptoms. Although more biological 
alternatives such as effector basophilic cells in conjunction 
with the protein array platform have been suggested as 
replacements for the skin prick test (LIN et al., 2007) thus 
far no significant technical progress has been achieved 
on this system.
3 Basophils
Once sensitised, basophils and mast cells are the 
effector cells in acute allergic reactions to food, including 
anaphylaxis (SANTOS et al., 2015). With a frequency of less 
than 1% of total white blood cells, human peripheral blood 
basophils are one of the rarest leukocytes. The purification 
of basophils therefore requires relatively sophisticated, 
multi-step purification protocols and large volumes of blood, 
which are time-consuming and expensive. Basophilic cells 
from peripheral blood are therefore not considered as 
standard laboratory reagents however, recent advances in 
the flow-assisted analysis of basophils, also known as the 
basophil activation test (BAT), have shown high sensitivity 
and specificity in the detection of traces of functionally 
active food allergens (SABATO et al., 2014). Moreover, 
BAT has been shown to be superior to other diagnostic 
tests in the discrimination between peanut allergic and 
peanut sensitised individuals, a disputed area in clinical 
diagnostics (SANTOS et al., 2014).
In order to obtain a more stable in vitro test, humanised 
rat basophilic leukaemia cells (RBL) have been engineered 
and used for monitoring specific allergen sensitisation in 
patient serum. Several humanised RBL cell lines have 
now been produced containing at least the human α chain 
of FcεRI, as human IgE does not bind to the rodent IgE 
receptor. FcεRI is expressed in human basophilic cells 
as the heterotetrameric αβγ2 form (NOVAK et al., 2001). 
While the α chain is responsible for IgE binding, the γ 
chain is responsible for signal transduction through the cell 
membrane. The β chain is thought to act as an enhancer 
of both surface expression and signal transduction. During 
basophilic activation a number of surface activation 
markers with different kinetics were used as reporters: 
CD13, CD63, CD107a CD164, CD203c (BUHRING et al., 
2004; HENNERSDORF et al., 2005), but the enzymatic 
release of β-hexosaminidase during degranulation is mainly 
used as the end point. A critical issue with these cell lines 
has been the cytotoxicity of certain human sera for rat 
cells, requiring high dilutions and resulting in insufficient 
sensitisation. A complete review on recent developments 
in RBLs can be found in (FALCONE; GIBBS, 2014; GIBBS; 
FALCONE, 2014) and their use in allergenicity assessment 
of food products in (VOGEL et al., 2006).
Recently it has been demonstrated that passive 
sensitization using the human mast cell (LAD2) reproduced 
in vitro the clinical reactivity to peanut in vivo (SANTOS et al., 
2015). This is an important landmark and opens an important 
precedent where cumbersome Skin Prick Tests and food 
challenges can potentially be replaced by in vitro cellular 
tests. With the availability of new cell lines (dendritic cells, 
NKT, gut epithelial) and a better understanding of the 
basic immunological mechanisms behind the sensitisation 
phase, the once dominated field of protein only allergens 
is now being challenged. More than ever it is becoming 
clear that accessory cells and other signals from the food 
matrix might play important roles in the overall allergenicity 
(MIROTTI et al., 2013).
4 Other IL-4 inducing cells
In recent studies investigating the basic mechanisms 
responsible for food allergy (CoFAR) it was demonstrated 
that the IL-4 expression in peripheral blood mononuclear 
cell (PMBC) was associated with clinical allergy to milk 
and peanut (CAUBET et al., 2014). Interestingly, by 
isolating the IL-2 receptor positive cells (CD25+ PBMC) 
no increase in GATA-3 was observed, suggesting that 
other non-T cells might be the source of IL-4. NK, NKT and 
basophils for instance were found in the CD25+ isolated 
http://bjft.ital.sp.gov.br
4Braz. J. Food Technol., Campinas, v. 19, e2016047, 2016
Recent advances in food allergy
Alcocer, M. J. C. et al.
cell population. It has been demonstrated that basophils 
might be important in priming and enhancing memory 
Th2 responses, and some authors have suggested that 
the MHC class II expressing basophils might also play a 
central role in antigen presentation (CAUBET et al., 2014).
Another strong indication that other cell types might 
have a significant role in allergenicity comes from the 
work on food matrixes, lipids and their signalling via NKT. 
Accumulating evidences demonstrated that large numbers 
of protein allergens possess a lipid binding site or lipid 
transfer functions. The presence of the hydrophobic site 
and the observation that other components co-presented 
with proteins can influence the initial stages of allergic 
sensitisation, are therefore of growing interest. It has been 
reported for instance that the cat allergen Fel d 1 cannot 
directly activate the immune system, but requires binding to 
the bacterial endotoxin LPS, which activates TLR4 via the 
MD2 protein (HERRE et al., 2013). It is also now apparent 
that non-bacterial components, such as lipids naturally 
present in pollen and nuts, can also activate the immune 
system and may play a role in allergic sensitisation. As with 
MD2 activation, this further suggests a potential involvement 
of activated innate immune response through endogenous 
“cargo” or “danger” signals (Toll-like, Dectin, Nod-like 
receptors) directly affecting the intrinsic allergenicity of 
lipid binding allergens from insects, nematodes, fungi 
and plants (GEORAS et al., 2010). This cargo signalling 
is particularly pronounced in our interaction with pollens 
for instance as has been well characterised in oral allergy 
syndromes (OAS). In initial studies, lipids have been 
profiled from 22 pollens and they demonstrated a wide 
variation among species, some with immune-stimulatory 
and other with immune-regulatory effects (BASHIR et al., 
2013). In another series of papers the well-described 
hydrophobic site of Bet v 1 was shown to bind a large 
number of hydrophobic molecules with a large range of 
biological activities, albeit with low specificity. Additionally, 
Pollen Associated Lipid Mediators (PALMs) have been 
isolated from pollen grains, that appear to modulate 
immune responses promoting a TH2 response favouring 
pro-allergic micromillieu in exposed tissues (GILLES et al., 
2009, 2010; BECK et al., 2012).
Besides the conventional toll receptors route, lipids 
may activate the immune system through processing and 
presentation via Antigen Presenting Cells (APCs) to Natural 
Killer T cells (NKT). NKT cells are a unique population of 
innate-like or natural memory T lymphocytes that exhibit the 
properties of both conventional T cells and NK cells. Once 
activated, NKT cells can rapidly secrete (within 1-2h) large 
amounts of Th1 and Th2 cytokines without clonal expansion 
that will activate various immune cells playing a central 
role, bridging innate and adaptive immune responses. 
The majority of NKT cells express highly restricted TCRs 
with an invariant α-chain (Vα24-Jα18 in humans and 
Vα14-Jα18 in mice) and limited β-chains, therefore they 
are referred to as Type I or invariant NKT cells (iNKT) 
(PEI et al., 2011; RHOST et al., 2012). Type II cells form 
the remaining NKT cells and express non-invariant TCRs. 
Most NKTs recognize lipid antigens presented by CD1, a 
MHC class I-like antigen-presenting molecule expressed 
in APCs. Natural ligands for CD1 include a wide range 
of both self and non-self glycolipids with one of the most 
potent CD1 ligands α-galactosylceramide, isolated from 
a marine sponge organism. Some pollen lipids have 
also been recognised via this pathway. Furthermore 
our group has shown that a natural lipid fraction from 
Brazil nut provided an essential adjuvant activity for 
sensitisation to the Brazil nut allergen Ber e 1, and that 
iNKT cells play a critical role in the development of Brazil 
nut-allergic response (MIROTTI et al., 2013). This work 
corroborated earlier work comparing PBMC responses 
from children with cow’s milk allergy (CMA), egg allergy 
with tolerance of milk, and healthy control subjects. In this 
work the authors showed that milk sphingomyelin could 
induce invariant natural killer T-cell activation and Th2 
cytokine production (JYONOUCHI et al., 2011). Are the 
NKTs or other similarly accessory regulatory cells the 
missing components for the establishment of the intrinsic 
allergenicity of proteins? It is interesting to note that this 
mechanism is conserved throughout our co-evolution 
history with parasites. Not surprisingly some parasites and 
parasite components have been shown to activate human 
NKT cells and activate a strong Th2 response that lead 
to IgE production. Indeed, whereas IgE appears to have 
evolved as a response to parasitic infestation to provide 
protection for the affected individual, allergic reactions are 
considered to be a purely pathologic consequence of the 
disruption of this immune response. With the development 
of new cell lines we might soon be able to test these ideas.
5 Microbiome/epigenetics
With the recent advances in microbiome and our 
incremental understanding of gut physiology, the whole area 
of food tolerance induced by the commensal bacteria and 
their epigenetic implication as modulators of the immune 
system is going through a major revolution. Initial animal 
studies on the effect of food allergy on the gut microbial 
ecology have demonstrated that disease-associated 
microbiota may play an important role in food allergy.
Food tolerance is arguably one of the first and most 
significant challenges that the gut immune system faces. 
From the sterile environmental of the womb, the newborn 
is exposed to a large array of new antigenic proteins in 
relatively high doses. Most of this foreign antigenic load 
is derived from colonizing commensal bacteria and food 
components. To prevent inflammatory responses to these 
largely harmless antigens, the gastrointestinal-associated 
lymphoid tissue has evolved complex mechanisms to 
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promote tolerance as a default response (PRESCOTT; 
ALLEN, 2011). Dendritic cells (DC) play a central role 
in the process, producing immunomodulatory cytokines 
(IL-10 and TGF-β), which suppress local inflammation 
in an antigen nonspecific manner. DC also promotes 
differentiation of antigen-specific regulatory T cells (Treg), 
essential for systemic immune surveillance and tolerance. 
In other systems it has been demonstrated that dietary 
factors can modify the heritable risk of allergic airway 
disease through epigenetic mechanisms during a period 
of foetal development in mice (HOLLINGSWORTH et al., 
2008). Thus it is possible that the increased risk of allergic 
disease might be a consequence of environmental 
heritable changes in gene expression in preceding 
generations (PRESCOTT; ALLEN, 2011). Animal studies 
have suggested that commensal microbiota might play 
a critical role in maintaining food tolerance. Food allergy 
prone mice that presented a mutation in the IL-4 receptor 
α chain (Il4raF709) were subjected to oral sensitization 
with chicken egg ovalbumin (OVA) and enforced tolerance 
achieved using allergen-specific regulatory T (Treg) cells. 
Interestingly the OVA-sensitized Il4raF709 mice exhibited 
a specific microbiota signature characterized by the 
abundance of taxa of several bacterial families, such as 
Lachnospiraceae, Lactobacillaceae, Rikenellaceae, and 
Porphyromonadaceae (RIVAS et al., 2013). Treatment of 
OVA-sensitized Il4raF709 mice with OVA-specific Treg 
cells led to a distinct tolerance-associated signature 
coincident with the suppression of the allergic response. 
Moreover the microbiota of allergen-sensitized Il4raF709 
mice differentially promoted OVA-specific IgE responses 
and anaphylaxis when reconstituted in WT germ-free mice 
(RIVAS et al., 2013). Thus it is possible that alterations in 
the composition of the microbiota (dysbiosis) disturb the 
partnership between the microbiota and the human immune 
system, ultimately leading to inflammatory disorders (ROUND; 
MAZMANIAN, 2009). Whether these alterations can be 
achieved by supplementation of pre-(pro) biotics remains 
to be shown (FORSBERG et al., 2013). Taken together the 
animal experiments linked to the recent developments on 
the production and use of T-regs in the treatment of some 
cancers suggest several interesting novel cellular and 
molecular pathways for modulation of the immunological 
responses (FEEHLEY; NAGLER, 2014). The important 
validation of the transfer of tolerance by microbiota to 
humans however, remains to be demonstrated.
6 New challenges and future
Recent reports from both Australia and the United 
States suggest that vitamin D might play a role in the 
recent increase in food allergy. Using indirect markers of 
food allergy status the results suggest that the further the 
patients reside from the equator, i.e. lowest ambient UV 
radiation, the more likely they will suffer from food allergy. 
Vitamin D levels are known to be associated with atopic 
disease development and the association of food allergy 
with latitude is most likely restricted to IgE-mediated 
mechanisms (OSBORNE et al., 2012). The existent data 
however, are controversial. In preliminary studies Vitamin 
D deficiency was associated with higher levels of IgE 
sensitization in children and adolescents (SHARIEF et al., 
2011). However later studies demonstrated that high vitamin 
D levels in pregnancy and at birth may contribute to a 
higher risk for food allergy and therefore argues against 
vitamin D supplementation to protect against allergy 
(WEISSE et al., 2013).
Regarding treatment, the last few years have 
witnessed interesting new ideas on oral, subcutaneous 
and epicutaneous desensitisation using a plethora of 
methods such as anti IgE antibodies (omalizumab), herbal 
therapy, chimeric allergen-IgG, Fcε blockage, lymph node 
injection and patch therapy amongst others (SICHERER; 
SAMPSON 2014). Some are now in clinical trial phase II, 
others have just gone through the feasibilities studies. 
Although interesting and promising, the actual validation 
of the efficacy in humans still remains to be demonstrated. 
In the area of tolerance some interesting progress has been 
reported on the acceleration of the resolution of cows’s milk 
and egg allergy in children, by increasing dietary baked 
allergen intake (KIM et al., 2011; LEONARD et al., 2012). 
The results from these controlled studies suggest that simple 
measures are better than complete avoidance. On the 
same desensitisation route, the group in Addenbrooke in 
Cambridge have successfully induced desensitization in 
children with different degrees of severity to peanut allergy. 
The peanut Oral Immune therapy (OIT) used was able to 
raise the reactive threshold to at least 25 times, and in some 
cases almost 90% of the participants could tolerate the daily 
ingestion of up to 800 mg protein (ANAGNOSTOU et al., 
2014). A recent development widely discussed in the 
2015 EAACI meeting refers to the use of epicutaneous 
immunotherapy (EPIT). French and American groups have 
shown that epicutaneous but not oral immunotherapy 
induced the generation of gastrointestinal-homing 
antigen-specific Tregs in the skin-draining lymph nodes, 
which translates into an increased number of Tregs in the 
gastrointestinal tract. The induction of gastrointestinal Tregs 
is associated with an enhanced protection of mice from 
food-induced anaphylaxis by EPIT (TORDESILLAS et al., 
2015). Some work, not yet published in humans, has also 
been discussed. The recent EPIT findings suggest the skin 
as a potent modulator of the allergic responses. This is 
interesting as in earlier work (2001-2003) the UK Avon 
Longitudinal study involving c.a. 14 000 families showed 
there was a possible link between the development of 
allergy to peanut and the use of creams on the skin to 
treat eczema. These findings and the recently reported 
cases of wheat-dependent exercise induced anaphylaxis 
patients sensitised to hydrolysed wheat protein in facial 
soap in Japan (HIRAGUN et al., 2013), corroborate the 
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skin as a potent modulator of allergic responses. Whether 
these responses could be exacerbated by the presence of 
lipids or surfactants and NKT involvement or suppressed 
by induction of T regs as in the EPIT system, remain to 
be demonstrated.
Regarding the timing and selection of specific 
complementary foods, many studies continue to suggest 
that prolonged avoidance of solids or specific allergens is 
not protective and might be a risk factor with regard to atopy 
or food allergy prevention (SICHERER; SAMPSON, 2014). 
In this regard one of the most interesting developments 
regarding the natural induction of tolerance is the recent 
findings by the Learning Early about Peanut Allergy (LEAP) 
study (DU TOIT et al., 2015). Peanut allergy develops early 
in life and as described above it is rarely outgrown. Clinical 
practice guidelines in the UK and USA recommended the 
exclusion of allergenic foods from the diets of infants at high 
risk for allergy and from the diets of their mothers during 
pregnancy and lactation. However, it was observed that 
the risk of the development of peanut allergy was 10 times 
as high among Jewish children in the United Kingdom as 
it was in Israeli children of similar ancestry. Furthermore 
it was noticed that in the UK infants do not consume 
peanut-based foods in their first year of life, whereas in 
Israel, peanut-based foods are usually introduced in the 
diet when the infants are approximately 7 months of age. 
This was the motivation behind the LEAP study aiming 
to determine whether an early introduction of peanuts 
would offer protection from developing peanut allergy. 
The initial findings of the LEAP study were impressive. 
The early introduction of peanuts significantly decreased 
the frequency of the development of peanut allergy among 
high-risk children when compared with peanut avoidance 
at the age of 60 months (DU TOIT et al., 2015). Although 
these are still initial results and many aspects of the 
study such as dosage and low/high risk-patients need 
to be worked out, this study has been pivotal in altering 
pre-conceived ideas. From the number of interim guidance 
and discussions prompted in a number of allergy related 
societies worldwide, one has an idea of the importance 
of these findings (FLEISCHER et al., 2015).
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